• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白藜芦醇通过调节微生物群、脑水肿和炎症在肝性脑病中的治疗应用

Therapeutic Applications of Resveratrol in Hepatic Encephalopathy through Its Regulation of the Microbiota, Brain Edema, and Inflammation.

作者信息

Kim Young-Kook, Song Juhyun

机构信息

Department of Biochemistry, Chonnam National University Medical School, Hwasun 58128, Jeollanam-do, Korea.

Department of Anatomy, Chonnam National University Medical School, Hwasun 58128, Jeollanam-do, Korea.

出版信息

J Clin Med. 2021 Aug 25;10(17):3819. doi: 10.3390/jcm10173819.

DOI:10.3390/jcm10173819
PMID:34501267
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8432232/
Abstract

Hepatic encephalopathy is a common complication in patients with liver cirrhosis and portosystemic shunting. Patients with hepatic encephalopathy present a variety of clinical features, including neuropsychiatric manifestations, cognitive dysfunction, impaired gut barrier function, hyperammonemia, and chronic neuroinflammation. These pathogeneses have been linked to various factors, including ammonia-induced oxidative stress, neuronal cell death, alterations in the gut microbiome, astrocyte swelling, and blood-brain barrier disruptions. Many researchers have focused on identifying novel therapeutics and prebiotics in the hope of improving the treatment of these conditions. Resveratrol is a natural polyphenic compound and is known to exert several pharmacological effects, including antioxidant, anti-inflammatory, and neuroprotective activities. Recent studies suggest that resveratrol contributes to improving the neuropathogenic effects of liver failure. Here, we review the current evidence describing resveratrol's effects in neuropathogenesis and its impact on the gut-liver axis relating to hepatic encephalopathy. We highlight the hypothesis that resveratrol exerts diverse effects in hepatic encephalopathy and suggest that these effects are likely mediated by changes to the gut microbiota, brain edema, and neuroinflammation.

摘要

肝性脑病是肝硬化和门体分流患者的常见并发症。肝性脑病患者呈现出多种临床特征,包括神经精神表现、认知功能障碍、肠道屏障功能受损、高氨血症和慢性神经炎症。这些发病机制与多种因素有关,包括氨诱导的氧化应激、神经元细胞死亡、肠道微生物群的改变、星形胶质细胞肿胀和血脑屏障破坏。许多研究人员致力于寻找新的治疗方法和益生元,以期改善这些病症的治疗效果。白藜芦醇是一种天然多酚化合物,已知具有多种药理作用,包括抗氧化、抗炎和神经保护活性。最近的研究表明,白藜芦醇有助于改善肝衰竭的神经致病作用。在此,我们综述了目前描述白藜芦醇在神经发病机制中的作用及其对与肝性脑病相关的肠-肝轴影响的证据。我们强调白藜芦醇在肝性脑病中发挥多种作用的假说,并表明这些作用可能是由肠道微生物群、脑水肿和神经炎症的变化介导的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3167/8432232/c6f563283324/jcm-10-03819-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3167/8432232/432e467579a7/jcm-10-03819-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3167/8432232/c6f563283324/jcm-10-03819-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3167/8432232/432e467579a7/jcm-10-03819-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3167/8432232/c6f563283324/jcm-10-03819-g002.jpg

相似文献

1
Therapeutic Applications of Resveratrol in Hepatic Encephalopathy through Its Regulation of the Microbiota, Brain Edema, and Inflammation.白藜芦醇通过调节微生物群、脑水肿和炎症在肝性脑病中的治疗应用
J Clin Med. 2021 Aug 25;10(17):3819. doi: 10.3390/jcm10173819.
2
The pathogenesis of gut microbiota in hepatic encephalopathy by the gut-liver-brain axis.肝性脑病通过肠-肝-脑轴的肠道微生物组发病机制。
Biosci Rep. 2023 Jun 28;43(6). doi: 10.1042/BSR20222524.
3
Gut Microbiota and Neuroinflammation in Acute Liver Failure and Chronic Liver Disease.急性肝衰竭和慢性肝病中的肠道微生物群与神经炎症
Metabolites. 2023 Jun 20;13(6):772. doi: 10.3390/metabo13060772.
4
Resveratrol Modulates the Gut-Brain Axis: Focus on Glucagon-Like Peptide-1, 5-HT, and Gut Microbiota.白藜芦醇调节肠-脑轴:聚焦于胰高血糖素样肽-1、5-羟色胺和肠道微生物群。
Front Aging Neurosci. 2020 Nov 24;12:588044. doi: 10.3389/fnagi.2020.588044. eCollection 2020.
5
Dietary approach and gut microbiota modulation for chronic hepatic encephalopathy in cirrhosis.肝硬化慢性肝性脑病的饮食方法与肠道微生物群调节
World J Hepatol. 2019 Jun 27;11(6):489-512. doi: 10.4254/wjh.v11.i6.489.
6
The neurogliovascular unit in hepatic encephalopathy.肝性脑病中的神经胶质血管单元。
JHEP Rep. 2021 Aug 11;3(5):100352. doi: 10.1016/j.jhepr.2021.100352. eCollection 2021 Oct.
7
Impaired Gut-Liver-Brain Axis in Patients with Cirrhosis.肝硬化患者肠道-肝脏-脑轴受损
Sci Rep. 2016 May 26;6:26800. doi: 10.1038/srep26800.
8
Fecal microbiota transplantation in hepatic encephalopathy: a systematic review.肝性脑病中的粪便微生物群移植:系统评价。
Scand J Gastroenterol. 2021 May;56(5):560-569. doi: 10.1080/00365521.2021.1899277. Epub 2021 Apr 10.
9
Gut Dysbiosis and Blood-Brain Barrier Alteration in Hepatic Encephalopathy: From Gut to Brain.肝性脑病中的肠道菌群失调与血脑屏障改变:从肠道到大脑
Biomedicines. 2023 Apr 25;11(5):1272. doi: 10.3390/biomedicines11051272.
10
Hyperammonemia induces neuroinflammation that contributes to cognitive impairment in rats with hepatic encephalopathy.高血氨血症引起的神经炎症导致肝性脑病大鼠认知功能障碍。
Gastroenterology. 2010 Aug;139(2):675-84. doi: 10.1053/j.gastro.2010.03.040. Epub 2010 Mar 18.

引用本文的文献

1
Pathophysiological-Based Nutritional Interventions in Cirrhotic Patients with Sarcopenic Obesity: A State-of-the-Art Narrative Review.基于病理生理学的营养干预在伴有肌肉减少症的肝硬化患者中的应用:最新的叙述性综述。
Nutrients. 2024 Jan 31;16(3):427. doi: 10.3390/nu16030427.
2
Curcumin-resveratrol nano-formulation counteracting hyperammonemia in rats.姜黄素-白藜芦醇纳米制剂拮抗大鼠高氨血症。
Metab Brain Dis. 2023 Apr;38(4):1365-1377. doi: 10.1007/s11011-023-01162-1. Epub 2023 Jan 25.

本文引用的文献

1
Pathomechanisms in hepatic encephalopathy.肝性脑病的发病机制。
Biol Chem. 2021 May 31;402(9):1087-1102. doi: 10.1515/hsz-2021-0168. Print 2021 Aug 26.
2
Disturbance of the Glutamate-Glutamine Cycle, Secondary to Hepatic Damage, Compromises Memory Function.继发于肝损伤的谷氨酸-谷氨酰胺循环紊乱会损害记忆功能。
Front Neurosci. 2021 Jan 27;15:578922. doi: 10.3389/fnins.2021.578922. eCollection 2021.
3
Resveratrol: A "miracle" drug in neuropsychiatry or a cognitive enhancer for mice only? A systematic review and meta-analysis.
白藜芦醇:神经精神药理学的“奇迹”药物,还是仅对小鼠有认知增强作用?系统评价和荟萃分析。
Ageing Res Rev. 2021 Jan;65:101199. doi: 10.1016/j.arr.2020.101199. Epub 2020 Oct 22.
4
Protection Against Ionizing Radiation-Induced Normal Tissue Damage by Resveratrol: A Systematic Review.白藜芦醇对电离辐射诱导的正常组织损伤的防护作用:一项系统综述。
Eurasian J Med. 2020 Oct;52(3):298-303. doi: 10.5152/eurasianjmed.2020.20143.
5
Resveratrol Modulates the Gut Microbiota and Inflammation to Protect Against Diabetic Nephropathy in Mice.白藜芦醇通过调节肠道微生物群和炎症来预防小鼠糖尿病肾病。
Front Pharmacol. 2020 Aug 19;11:1249. doi: 10.3389/fphar.2020.01249. eCollection 2020.
6
Current Update on Preclinical and Clinical Studies of Resveratrol, a Naturally Occurring Phenolic Compound.白藜芦醇(一种天然存在的酚类化合物)的临床前和临床研究的最新进展
Crit Rev Eukaryot Gene Expr. 2019;29(6):529-537. doi: 10.1615/CritRevEukaryotGeneExpr.2019027836.
7
Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis.用白藜芦醇靶向肠道微生物群:管理肝脂肪变性的新证据的例证。
J Nutr Biochem. 2020 Jul;81:108363. doi: 10.1016/j.jnutbio.2020.108363. Epub 2020 Feb 27.
8
Resveratrol reduces cerebral edema through inhibition of de novo SUR1 expression induced after focal ischemia.白藜芦醇通过抑制局灶性缺血后新表达的 SUR1 减轻脑水肿。
Exp Neurol. 2020 Aug;330:113353. doi: 10.1016/j.expneurol.2020.113353. Epub 2020 May 4.
9
The Molecular and Mechanistic Insights Based on Gut-Liver Axis: Nutritional Target for Non-Alcoholic Fatty Liver Disease (NAFLD) Improvement.基于肠-肝轴的分子和机制见解:改善非酒精性脂肪性肝病(NAFLD)的营养靶点。
Int J Mol Sci. 2020 Apr 26;21(9):3066. doi: 10.3390/ijms21093066.
10
Reperfusion combined with intraarterial administration of resveratrol-loaded nanoparticles improved cerebral ischemia-reperfusion injury in rats.载白藜芦醇纳米粒再灌注联合动脉内给药改善大鼠脑缺血再灌注损伤。
Nanomedicine. 2020 Aug;28:102208. doi: 10.1016/j.nano.2020.102208. Epub 2020 Apr 23.